Please note, this OEL/ADE monograph also applies to piribedil mesylate (CAS RN 52293-23-9), piribedil hydrochloride (CAS RN 78213-63-5), piribedil maleate (CAS RN 937719-94-3), and piribedil dihydrochloride (CAS RN not available). Piribedil is an alternative therapy to patients who have not responded to levodopa therapy with bromocriptine. Although piribedil has improved symptoms of Parkinson's disease, particularly when administered as add-on therapy in multiple-drug regimens, available clinical studies with this agent are still limited and the number of patients treated with piribedil is limited.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Piribedil, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.